<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43BEDA5F-E824-412D-A4AC-ED7F1139F5CC"><gtr:id>43BEDA5F-E824-412D-A4AC-ED7F1139F5CC</gtr:id><gtr:name>University of Turin</gtr:name><gtr:address><gtr:line1>Via Giuseppe Verdi 8</gtr:line1><gtr:postCode>I-10124</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Population Health</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43BEDA5F-E824-412D-A4AC-ED7F1139F5CC"><gtr:id>43BEDA5F-E824-412D-A4AC-ED7F1139F5CC</gtr:id><gtr:name>University of Turin</gtr:name><gtr:address><gtr:line1>Via Giuseppe Verdi 8</gtr:line1><gtr:postCode>I-10124</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D1C5947D-8FD1-4F79-A0C9-C0432A8D2B38"><gtr:id>D1C5947D-8FD1-4F79-A0C9-C0432A8D2B38</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:otherNames>McIntosh</gtr:otherNames><gtr:surname>Gray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C7FC9B83-E816-444C-82B4-22EB56516EE6"><gtr:id>C7FC9B83-E816-444C-82B4-22EB56516EE6</gtr:id><gtr:firstName>Borislava</gtr:firstName><gtr:surname>Mihaylova</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EFD45811-4379-4FD0-A939-474D5068C89B"><gtr:id>EFD45811-4379-4FD0-A939-474D5068C89B</gtr:id><gtr:firstName>Rury</gtr:firstName><gtr:surname>Holman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EB3BB86C-BFD7-46F1-8CD3-5EFD09F9D198"><gtr:id>EB3BB86C-BFD7-46F1-8CD3-5EFD09F9D198</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C2B0F1D4-0091-460E-9AF9-73C67CC224B0"><gtr:id>C2B0F1D4-0091-460E-9AF9-73C67CC224B0</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Goldacre</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801042"><gtr:id>AE409F2D-9A84-410B-9516-6BB9ABBE5964</gtr:id><gtr:title>An outcomes model for type 2 diabetes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801042</gtr:grantReference><gtr:abstractText>Type 2 diabetes is an increasingly common chronic disease which can cause a wide range of serious complications including heart disease and blindness. We propose improving and making widely accessible a model which simulates the likely course of the disease for patients, given their particular characteristics such as blood pressure, current age and time since diagnosis. The model is based on information from patients in the United Kingdom Prospective Diabetes Study, a landmark study of diabetes treatment. It has already been found to give more accurate predictions than other diabetes models, and is being used by researchers in many countries. Some elements now need to be updated, and it needs to be made more user-friendly. Our model will then give patients and their doctors valuable information on current prognosis and the benefits of therapy. The usefulness of the model to other researchers will also be greatly enhanced.</gtr:abstractText><gtr:technicalSummary>The prevalence of Type 2 diabetes is increasing, and it is associated with a wide range of serious complications including heart disease and blindness. Because of its potentially long duration, simulation models are particularly valuable in understanding and estimating the lifetime risk of complications and the effects of modifying risk factors. The United Kingdom Prospective Diabetes Study Outcomes Model is a well-established and validated model based on patient-level data from this landmark study of diabetes treatment. It has already been found to compare favourably with other diabetes models in predictive comparions, and is being used by academic researchers, reimbursement and other public agencies and industry in many countries. This research proposal has three elements: first to implement a set of model improvements and updates, in particular focusing on changes in fatality rates following diabetes-related complications and changes in death from other causes; second, to undertake a wide-ranging set of external validations, comparing model predictions of event rates given baseline characteristics and risk factor changes against observed event rates in a large number of recent trials; and third to significantly improve the usability and accessibility of the model, both for the research community and so that patients and their doctors can readily use it to obtain valuable information on current prognosis and the benefits of therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>465563</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern Denmark</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Odense</gtr:description><gtr:id>7FAB0346-3293-4B19-BF97-1D4B8366260D</gtr:id><gtr:impact>No outputs so far.</gtr:impact><gtr:outcomeId>fDt7XwfRuuw-1</gtr:outcomeId><gtr:partnerContribution>The University of Southern Denmark is supporting the student to visit Oxford, and is providing access to data for the model simulation.</gtr:partnerContribution><gtr:piContribution>I have set up a visiting scholar arrangement to enable a doctoral student from Odense to spend time in Oxford while working on her thesis, and in particular to use the new version of the UKPDS Outcomes Model to make prediction using a Danish cohort of diabetic patients. I will supervise the work programme and outputs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>School of Population Health</gtr:department><gtr:description>Melbourne</gtr:description><gtr:id>843CAACC-2B33-42BD-BFEB-929684DA4714</gtr:id><gtr:impact>Hayes AJ, Leal J, Gray A, Holman RR, Clarke PM. UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30-year United Kingdom Prospective Diabetes Study. (UKPDS no. 82). Diabetologia 2013; 56(9):1925-33. doi: 10.1007/s00125-013-2940-y. PMID: 23793713.</gtr:impact><gtr:outcomeId>TWwrhcZhBQK-1</gtr:outcomeId><gtr:partnerContribution>The Melbourne (and Sydney) researchers have been mainly involved in re-estimating risk equations.</gtr:partnerContribution><gtr:piContribution>My collaborator Philip Clarke moved from Sydney to the University of Melbourne in 2012, and we have continued to work closely together on the development and application of the UKPDS Outcomes Model. My team has been responsible for determining changes to the software, generating new cost and utility estimates for complications, estimating risk factor equations, and assessing the external validity of the model using record linked UK data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Turin</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Epidemiology</gtr:department><gtr:description>Turin cohort study</gtr:description><gtr:id>AC904A95-5102-4320-9065-60BC2EE87648</gtr:id><gtr:impact>Pagano E, Gray A, Rosato R, Gruden G, Cavallo Perin P, Merletti F, Bruno G. Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato survey, Italy. Diabetologia 2013; 56(8):1726-34. doi: 10.1007/s00125-013-2933-x. PMID: 23680916</gtr:impact><gtr:outcomeId>MdUNvnh78gS-1</gtr:outcomeId><gtr:partnerContribution>My partners in Turn provided access to the cohort study (Casale Monferrato), inputted the data, performed model runs, and drafted a manuscript in collaboration with myself.</gtr:partnerContribution><gtr:piContribution>I visited Turn, gave a departmental lecture on the UKPDS Outcomes Model, and established a research collaboration to use the model to make predictions on an Italian diabetes cohort, and then compare predictions with actual outcomes.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Mount Hood Baltimore 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>16A3BA9A-47AE-49F5-A145-251B77A450AF</gtr:id><gtr:impact>7th June 2012: Mt Hood Challenge, John Hopkins University, Baltimore, USA, &amp;quot;Inpatient and Outpatient Resource use in Patients with type-2 Diabetes: New Evidence from the UKPDS&amp;quot;


This meeting is a key group of international diabetes modelers who meet regularly to compare models and methods.</gtr:impact><gtr:outcomeId>Bs7J4AYitbs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Using the UKPDS Outcomes Model, and other models, for individual prognosis. Medical University of Vienna 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B27C885-B058-44C1-AC8F-CB49CCF14AC2</gtr:id><gtr:impact>High level of interest in half-day meeting; future event will be linked to European Association for the Study of Diabetes conference.

future event will be linked to European Association for the Study of Diabetes conference.</gtr:impact><gtr:outcomeId>545ccca020ca13.75262991</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford 2010 2</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CE079B62-BB21-4818-A0DD-682918B9BF20</gtr:id><gtr:impact>2nd June 2010: HERC Research Discussion meetings, Oxford. &amp;quot;Estimating the quality of life impact of diabetes related complications over time&amp;quot;.

A presentation within our group to ensure colleagues were fully informed.</gtr:impact><gtr:outcomeId>eaS4hd5qBJ6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mount Hood meeting, Stanford University 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3E8DDDD9-8838-4E67-9CB4-98EBF4D322C8</gtr:id><gtr:impact>Talk: &amp;quot;Diabetes modelling using the UKPDS Outcomes Model&amp;quot;, stimulated academic exchanges of views on this area of research

Results of &amp;quot;challenge&amp;quot; comparing different diabetes models will be prepared as a manuscript for publication.</gtr:impact><gtr:outcomeId>545ccbab52acb6.77970337</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>paper presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>08D99EFB-D804-476F-B6AA-9DD007BA6486</gtr:id><gtr:impact>3rd of March 2011: Public Health Work in Progress Seminar, Oxford &amp;quot;Outpatient Resource use in Patients with type-2 Diabetes&amp;quot;.

Several doctoral students asked for further information on methods.</gtr:impact><gtr:outcomeId>DgHYNA3upy1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to general practitioners, Warwick 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>229B56FE-F06A-4B07-B904-099F479444A3</gtr:id><gtr:impact>About 60 GPs, diabetologists, managers of primary care trusts and diabetic nurses attended the event.

I was asked to forward copies of slides to several people attending.</gtr:impact><gtr:outcomeId>WQLmQVsD3c5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University College London Symposium, May 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43245F72-CB63-4F29-A031-668530FEF038</gtr:id><gtr:impact>Talk-title: &amp;quot;Reversing Trends in Diabetes 2012&amp;quot;. The costs of diabetes-related complications and the impact of changes in risk factors.</gtr:impact><gtr:outcomeId>56d987fc274071.88143452</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford 2011 2</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8F37FBAE-8DA1-40B0-9F7F-166F7BC171AC</gtr:id><gtr:impact>12th December 2011: HERC Research Discussion meetings, &amp;quot;Is Self-reported quality of life an independent predictor of Survival?&amp;quot; Oxford.

Several colleagues made valuable suggestions about future research directions and new applications.</gtr:impact><gtr:outcomeId>JT67rSAZQum</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B1664F6C-6833-4719-B70B-95375C1479E9</gtr:id><gtr:impact>11th of February 2010: Public Health Work in Progress Seminar, Oxford &amp;quot;The Impact of Diabetes-Related Complications on Hospital-in-patient Costs&amp;quot;.

Other researchers working in related fields were able to compare and share methods following this.</gtr:impact><gtr:outcomeId>TUcMi29WDeB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An updated version of the disease model. It is now fully documented with details in a peer reviewed publication, and a revised software version is being completed with a completion date of |December 2013.</gtr:description><gtr:id>5B6F736A-2EBD-4EAF-9385-AC612D1461C7</gtr:id><gtr:impact>We are receiving enquiries internationally about this new version of the model and its applicability to different patient groups. It is being used in the UK by NICE to help form future diabetes guidelines.</gtr:impact><gtr:outcomeId>aQqdTTh8dUw</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UKPDS Outcomes Model v2</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A spreadsheet based disease model to predict the lifetime risks and complications of type 2 diabetes. A revised version has been made available as of November 2010. We have produced a second version, available as a piece of software.</gtr:description><gtr:id>2032FF1E-6300-40FF-A30C-747189B0E255</gtr:id><gtr:impact>Other publications have made use of this model. There has also been interest from epidemiologists, doctoral students, and an impaired annuity insurance company, which wishes to make use of our model when writing policies. The model has been used by the National Institute for Health and Clinical Excellence to evaluate new and existing drug therapies on behalf of the National Health Service.</gtr:impact><gtr:outcomeId>Exs25SEwDuB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UKPDS Outcomes Model</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2D282D42-6A33-4E1E-A0D6-6BD628FA92DF</gtr:id><gtr:title>The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity.</gtr:title><gtr:parentPublicationTitle>Health economics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bacae220ab98d2708978f6772a4500a"><gtr:id>2bacae220ab98d2708978f6772a4500a</gtr:id><gtr:otherNames>Alva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1057-9230</gtr:issn><gtr:outcomeId>pm_12496_26_23847044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0200A4A-4585-4074-86F8-8236637C368D</gtr:id><gtr:title>Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0669e9e1ad7202d315f3b53701b838"><gtr:id>1b0669e9e1ad7202d315f3b53701b838</gtr:id><gtr:otherNames>Leal J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>5a85bd93691188.14673831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>777407A3-0777-46AE-8B6E-63B8EF086952</gtr:id><gtr:title>The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe8e1c7ac92ae69ca52073315f3d9360"><gtr:id>fe8e1c7ac92ae69ca52073315f3d9360</gtr:id><gtr:otherNames>Alva ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>545cc9b55fde54.93856890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>531DEE3E-E6A5-4480-B7AF-290D4612B17F</gtr:id><gtr:title>A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Preventive medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/561dad709a0c7a519b602a4ab102ee03"><gtr:id>561dad709a0c7a519b602a4ab102ee03</gtr:id><gtr:otherNames>Davies MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-7435</gtr:issn><gtr:outcomeId>56cdd258baaeb4.49590958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D853E44C-47FB-4AD7-9A59-D42451F1FFC2</gtr:id><gtr:title>Diabetes: costs and cost-effectiveness.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab3e1449504c11a6217766561b3927b4"><gtr:id>ab3e1449504c11a6217766561b3927b4</gtr:id><gtr:otherNames>Gray AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>pm_12496_26_20722668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60B2E88E-4C72-4E83-8552-5CFF094029BF</gtr:id><gtr:title>UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e5cc485e966650112d54661656e4cc3"><gtr:id>3e5cc485e966650112d54661656e4cc3</gtr:id><gtr:otherNames>Hayes AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12496_26_23793713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B7D2361-9952-48E1-B50F-CAA310D609B4</gtr:id><gtr:title>Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b0669e9e1ad7202d315f3b53701b838"><gtr:id>1b0669e9e1ad7202d315f3b53701b838</gtr:id><gtr:otherNames>Leal J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>LcjS3JYApZk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>740A3AF1-105B-4821-972C-F8EC6D14956B</gtr:id><gtr:title>Modelling incremental benefits on complications rates when targeting lower HbAlevels in people with Type 2 diabetes and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/177e61c9587c0ee4f35dee2abb58ab5b"><gtr:id>177e61c9587c0ee4f35dee2abb58ab5b</gtr:id><gtr:otherNames>Mostafa SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>5a85bd236db466.54335949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E72FFF1E-7350-4391-8D61-5722308D68CF</gtr:id><gtr:title>Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5631dedc2427abc7e8fe281458752202"><gtr:id>5631dedc2427abc7e8fe281458752202</gtr:id><gtr:otherNames>Palmer AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>pm_12496_26_23796302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A563F4F-F9FF-4E69-888A-C2F83C303757</gtr:id><gtr:title>Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89f211527a64d49b8dae3e89573b7e27"><gtr:id>89f211527a64d49b8dae3e89573b7e27</gtr:id><gtr:otherNames>Pagano E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12496_26_23680916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46FD4F1B-8898-43FE-B57F-331B8BD99550</gtr:id><gtr:title>Life expectancy in individuals with type 2 diabetes: implications for annuities.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2be89ada99bf12595d6858ce253b98ed"><gtr:id>2be89ada99bf12595d6858ce253b98ed</gtr:id><gtr:otherNames>Price HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>pm_12496_26_20042534</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801042</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>B7F5A9CA-62C7-4E68-A2B2-3D6CCA85E16B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>7.3  Management and decision making</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>